SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-027034
Filing Date
2023-09-28
Accepted
2023-09-28 16:09:35
Documents
15
Period of Report
2023-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20230928c_8k.htm   iXBRL 8-K 32917
2 EXHIBIT 99.1 ex_574401.htm EX-99.1 13570
7 modexlogo.jpg GRAPHIC 27555
  Complete submission text file 0001437749-23-027034.txt   222258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20230928.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20230928_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20230928_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20230928_pre.xml EX-101.PRE 11581
9 EXTRACTED XBRL INSTANCE DOCUMENT opk20230928c_8k_htm.xml XML 2566
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 231289701
SIC: 2834 Pharmaceutical Preparations